Early Use of Statins in Diabetes Patients Significantly Lowers Heart Attack and Stroke Risks

Initiating statin therapy promptly in patients with diabetes is a proven, safe, and cost-effective strategy to reduce the risk of cardiovascular events, such as heart attacks and strokes. Despite strong clinical guidelines recommending statin use for these patients, nearly 20% delay starting the medication, often opting to try lifestyle changes or alternative drugs first.

A recent study conducted by researchers from Mass General Brigham emphasizes the importance of early statin initiation. The study revealed that patients who began statin treatment immediately experienced about a one-third decrease in the incidence of heart attacks and strokes compared to those who deferred treatment. These findings, published in the Journal of the American Heart Association, aim to support healthcare providers and patients in making informed decisions about lipid management.

Dr. Alexander Turchin, the senior author and a specialist at Brigham and Women's Hospital, underscores the urgency of early intervention. "I recommend statins to all eligible patients with diabetes because other interventions are less effective at lowering cholesterol. Starting statins early can significantly protect your heart and brain health."

Heart disease and cerebrovascular accidents are leading causes of death among people with diabetes, primarily driven by the buildup of plaque in blood vessels. Statins help prevent this process, ensuring proper blood flow and oxygen delivery to vital organs.

The study analyzed electronic health records from 7,239 patients over nearly two decades. The median age was 55, with a slight majority being women and white. Notably, 17.7% initially declined statin therapy but later accepted it, usually around 1.5 years later after re-evaluation. Those who delayed treatment had an 8.5% rate of heart attack or stroke, compared to 6.4% among those who started medication immediately.

This research highlights the importance of shared decision-making in clinical practice, encouraging clinicians to address the risks associated with delaying statin therapy and advocate for timely treatment to improve long-term cardiovascular health in patients with diabetes.

Source: MedicalXpress